Activating Compound | Comment | Organism | Structure |
---|---|---|---|
(2S)-1-([2-[(2S)-2-aminopropanoyl]-1-(prop-2-en-1-yl)hydrazinyl]carbonyl)-N-(diphenylmethyl)pyrrolidine-2-carboxamide (non-preferred name) | - |
Homo sapiens | |
(2S)-1-([2-[(2S)-2-aminopropanoyl]-1-(prop-2-yn-1-yl)hydrazinyl]carbonyl)-N-(diphenylmethyl)pyrrolidine-2-carboxamide (non-preferred name) | - |
Homo sapiens | |
(2S)-1-([2-[(2S)-2-aminopropanoyl]-1-benzylhydrazinyl]carbonyl)-N-(diphenylmethyl)pyrrolidine-2-carboxamide (non-preferred name) | - |
Homo sapiens | |
(2S)-1-([2-[(2S)-2-aminopropanoyl]-1-methylhydrazinyl]carbonyl)-N-(diphenylmethyl)pyrrolidine-2-carboxamide (non-preferred name) | - |
Homo sapiens | |
(2S)-1-([2-[(2S)-2-aminopropanoyl]hydrazinyl]carbonyl)-N-(diphenylmethyl)pyrrolidine-2-carboxamide (non-preferred name) | - |
Homo sapiens | |
additional information | activation of caspase-9 via proteolytic cleavage. Design and synthesis of azapeptide activators of apoptosis mediated by caspase-9 in cancer cells, a set of azapeptides was designed based on the Ala-Val-Pro-Ile peptide (derived from second mitochondria-derived activator of caspase, Smac, protein) to activate caspase-9 and induce apoptosis in breast cancer cells. overview | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(3S,6S,10aS)-6-(L-alanylamino)-N-(diphenylmethyl)-5-oxodecahydropyrrolo[1,2-a]azocine-3-carboxamide | - |
Homo sapiens | |
(3S,6S,8aS)-6-(L-alanylamino)-N-(diphenylmethyl)-5-oxooctahydroindolizine-3-carboxamide | - |
Homo sapiens | |
(3S,6S,9aS)-6-(L-alanylamino)-N-(diphenylmethyl)-5-oxooctahydro-1H-pyrrolo[1,2-a]azepine-3-carboxamide | - |
Homo sapiens | |
L-alanyl-L-valyl-L-prolyl-L-isoleucinamide | - |
Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Posttranslational Modification | Comment | Organism |
---|---|---|
proteolytic modification | activation of caspase-9 via proteolytic cleavage | Homo sapiens |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
breast cancer cell | - |
Homo sapiens | - |
MDA-MB-231 cell | - |
Homo sapiens | - |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.000014 | - |
(3S,6S,10aS)-6-(L-alanylamino)-N-(diphenylmethyl)-5-oxodecahydropyrrolo[1,2-a]azocine-3-carboxamide | pH and temperature not specified in the publication | Homo sapiens | |
0.00006 | - |
(3S,6S,9aS)-6-(L-alanylamino)-N-(diphenylmethyl)-5-oxooctahydro-1H-pyrrolo[1,2-a]azepine-3-carboxamide | pH and temperature not specified in the publication | Homo sapiens | |
0.00058 | - |
L-alanyl-L-valyl-L-prolyl-L-isoleucinamide | pH and temperature not specified in the publication | Homo sapiens | |
0.00233 | - |
(3S,6S,8aS)-6-(L-alanylamino)-N-(diphenylmethyl)-5-oxooctahydroindolizine-3-carboxamide | pH and temperature not specified in the publication | Homo sapiens |
General Information | Comment | Organism |
---|---|---|
metabolism | activation of caspase-9 and caspase-3 via proteolytic cleavage is crucial for the regulation of the apoptotic program | Homo sapiens |
physiological function | caspase-3 activation is induced by caspase-9 | Homo sapiens |